Nigeria: HIV Vaccine Moves One Step Closer to Reality

6 July 2017

SCIENTISTS from The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology (LJI) may have found the best delivery mode for a vaccine against HIV.

A publication in ContagionLive said the results of their new study show that "optimizing the mode and timing of vaccine delivery is crucial to inducing a protective immune response in a practical model," a press release on the study stated. For their study, published in the journal, Immunity, the scientists found that, "administering the vaccine candidate subcutaneously and increasing the time intervals between immunizations improved the efficacy of the experimental vaccine and reliably induced neutralizing antibodies." These antibodies are key in promoting an effective immune response as they inactivate an invading virus before it is able to set up shop in the body.

...

AllAfrica publishes around 500 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.